High molecular weight epithelial mucins as markers in breast cancer

Burchell, 1983, Complexity of expression of antigenic determinants recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells, J Immunol, 131, 508, 10.4049/jimmunol.131.1.508 Hilkens, 1984, Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumours, Int J Cancer, 34, 197, 10.1002/ijc.2910340210 Price, 1985, Multiple epitopes on a human breast carcinoma associated antigen, Int J Cancer, 36, 567, 10.1002/ijc.2910360509 Sekine, 1985, Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas, J Immunol, 135, 3610, 10.4049/jimmunol.135.5.3610 Papsidero, 1984, Immunoaffinity isolation of ductal carcinoma antigen using monoclonal antibody F36/22, Mol Immunol, 21, 955, 10.1016/0161-5890(84)90153-6 Shimizu, 1982, Isolation and characterization of mucin-like glycoprotein in human milk fat globule membrane, J Biochem, 91, 515, 10.1093/oxfordjournals.jbchem.a133724 Burchell, 1987, Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin, Cancer Res, 47, 5476 Swallow, 1986, Detection of the urinary ‘PUM’ polymorphism by the tumour binding monoclonal antibodies Ca1, Ca2, Ca3, HMFG-1 and HMFG-2, Disease Markers, 4, 247 Crocker, 1987, Genetic polymorphism of high molecular weight urinary glycoproteins: a comparative study in normal individuals and breast cancer patients, Br J Cancer, 55, 651, 10.1038/bjc.1987.132 Griffiths, 1988, The tumour associated epithelial mucins and the peanut lectin binding urinary mucins appear to be coded by a single highly polymorphic gene locus ‘PUM’, Disease Markers, 6, 185 Swallow, 1987, The tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM, Nature, 327, 82, 10.1038/328082a0 Gendler, 1987, Cloning the cDNA coding for differentiation and tumor-associated glycoproteins expressed by human mammary epithelium, 84, 6060 Siddiqui, 1988, Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen, 85, 2320 Hayes, 1988, Genetically determined polymorphism of the circulating human breast cancer-associated DF3 antigen, Blood, 71, 436, 10.1182/blood.V71.2.436.436 Price, 1988, Breast cancer associated antigens, 1 Zotter, 1988, Tissue distribution of high molecular weight epithelial sialomucins: a comparative study using 20 monoclonal antibodies, Cancer Res Price, 1986, Epitopes with diagnostic and prognostic significance co-expressed on a human breast carcinoma-associated antigen, Eur J Cancer Clin Oncol, 22, 115, 10.1016/0277-5379(86)90351-2 Price, 1986, Epitope analysis of monoclonal antibody NCRC-11 defined antigen isolated from human ovarian and breast carcinomas, Br J Cancer, 54, 393, 10.1038/bjc.1986.189 Price, 1987, Identification of a monoclonal antibody defined breast carcinoma antigen in body fluids, Eur J Cancer Clin Oncol, 23, 1169, 10.1016/0277-5379(87)90151-9 O'Sullivan, 1988, Characteristics of a breast cancer antigen isolated from patients' sera, Br J Cancer, 58, 244 Lan, 1987, Co-expression of human cancer-associated epitopes on mucin molecules, Int J Cancer, 39, 68, 10.1002/ijc.2910390112 Abe, 1987, Identification of a family of high molecular weight tumor-associated glycoproteins, J Immunol, 139, 257, 10.4049/jimmunol.139.1.257 Bramwell, 1985, Ca2 and Ca3, 56, 105 Linsley, 1988, Monoclonal antibodies reactive with mucin glycoproteins found in sera from breast cancer patients, Cancer Res, 48, 2138 Foster, 1984, Monoclonal antibodies to the human mammary gland: III. Monoclonal antibody LICR-LON-M18 identifies impaired expression and excess sialylation of the I(Ma) cell-surface antigen by primary breast carcinoma cells, Hum Pathol, 15, 502, 10.1016/S0046-8177(84)80003-9 McIlhinney, 1985, Monoclonal antibodies recognizing epitopes carried on both glycolipids and glycoproteins of the human milk fat globule membrane, Biochem J, 227, 155, 10.1042/bj2270155 Epenetos, 1982, Use of two epithelium specific monoclonal antibodies for diagnosis of malignancy in serous effusions, Lancet, ii, 1004, 10.1016/S0140-6736(82)90047-2 Heyderman, 1979, A new antigen on the epithelial membrane: its immunoperoxidase localization in normal and neoplastic tissues, J Clin Pathol, 32, 35, 10.1136/jcp.32.1.35 Sloane, 1981, Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumour pathology, Cancer, 47, 1786, 10.1002/1097-0142(19810401)47:7<1786::AID-CNCR2820470711>3.0.CO;2-8 Dearnaley, 1981, Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen, Br J Cancer, 44, 85, 10.1038/bjc.1981.152 Gatter, 1984, The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies, Am J Clin Pathol, 82, 33, 10.1093/ajcp/82.1.33 Nuti, 1986, Use of monoclonal antibodies to human breast tumor associated antigens in fine needle aspirate cytology, Int J Cancer, 37, 493, 10.1002/ijc.2910370404 Heyderman, 1985, A new monoclonal antibody to epithelial membrane antigen (EMA)—E29, 52, 355 Edwards, 1985, Heterogeneous expression of cell surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies, Br J Cancer, 51, 149, 10.1038/bjc.1985.24 Ellis, 1985, Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC-11—a new prognostic indicator, Br Med J, 290, 881, 10.1136/bmj.290.6472.881 Ellis, 1987, Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma, Br J Cancer, 56, 295, 10.1038/bjc.1987.192 Burchell, 1984, Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in the serum from patients with breast cancer, Int J Cancer, 34, 763, 10.1002/ijc.2910340605 Hilkens, 1985, MAM-6, a carcinoma associated marker: preliminary characterization and detection in sera of breast cancer patients, 28 Hilkens, 1986, MAM-6 antigen, a new serum marker for breast cancer monitoring, Cancer Res, 46, 2582 Hilkens, 1987, Comparison of circulating MAM-6 and CEA levels and correlation with estrogen receptor in patients with breast cancer, Int J Cancer, 39, 431, 10.1002/ijc.2910390403 Hayes, 1985, Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients, J Clin Invest, 75, 1671, 10.1172/JCI111875 Stacher, 1988, Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA, Br J Cancer, 57, 298, 10.1038/bjc.1988.66 Kufe, 1988, Monoclonal antibody assays for breast cancer, Volume 39, 67 Bray, 1987, Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker, Cancer Res, 47, 5853 Ashorn, 1988, Elevated serum HMFG antigen levels in breast and ovarian cancer patients measured with a sandwich ELISA, Int J Cancer, 28, 10.1002/ijc.2910410710 Rainsbury, 1983, Location of metastatic breast carcinoma by monoclonal antibody chelate labelled with indium-111, Lancet, ii, 934, 10.1016/S0140-6736(83)90452-X Ward, 1987, Circulating tumour-associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancer, Int J Cancer, 39, 30, 10.1002/ijc.2910390107 Epenetos, 1982, Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours, Lancet, ii, 999, 10.1016/S0140-6736(82)90046-0 Britton, 1985, Localisation of cancer of the ovary and metastases using 123I-labelled monoclonal antibody HMFG-2 compared to surgical findings, 201 Epenetos AA. Antibody guided irradiation of malignant lesions: three cases illustrating a new method of treatment—a report of the Hammersmith Oncology Group and the Imperial Cancer Research Fund. Lancet i, 1441–1443. Pectasides, 1986, Antibody-guided irradiation of malignant pleural and pericardial effusions, Br J Cancer, 53, 727, 10.1038/bjc.1986.125 Ward, 1987, Localization of radioiodine conjugated to the murine monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administration, Cancer Res, 47, 4719 Kenemans, 1988, Mucins and mucin-like antigens as circulating tumor markers, Vol. 11